1. PTU-109 Development of a gastroenterology-led patient-centred service for neuroendocrine tumours(NETS) in wales:population-based national commissioning. (8th June 2018) Authors: Khan, Mohid Shakil; Reynolds, Mark; Bell, Carole; Hopps, Rebecca; Powell, Catherine; Morgan, Carys; Gwynne, Sarah; Rees, Dafydd Aled; Christian, Adam Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Health-related quality of life (HRQoL) in patients (pts) with progressive, poorly differentiated, extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC) enrolled in NET-02: A phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy. Issue 28 (1st October 2022) Authors: Craig, Zoe; Swain, Jayne; Sharma, Rohini; Faluyi, Olusola Olusesan; Wadsley, Jonathan; Morgan, Carys; Wall, Lucy R.; Chau, Ian; Reed, Nicholas Simon; Sarker, Debashis; Margetts, Jane; Krell, Daniel; Cave, Judith; Sharmila, Sothi; Anthoney, Alan; Patel, Alkesh; Lamarca, Angela; Hubner, Richard A; ... Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The impact of tyrosine kinase inhibitors on the treatment of gastrointestinal stromal tumours (GISTs): The Velindre Cancer Centre experience. Issue 11 (November 2016) Authors: Ashdown, Thomas; Morgan, Carys Journal: European journal of surgical oncology Issue: Volume 42:Issue 11(2016:Nov.) Page Start: S253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗